Recording date: 20th October 2025

In a comprehensive analysis of uranium market fundamentals, Purepoint Uranium CEO Chris Frostad has clarified widespread misconceptions about supply and demand forecasts that have misled investors in recent years. His white paper examining World Nuclear Association (WNA) data reveals that industry reports are planning tools for utilities and governments, not predictive investment models.

Frostad emphasizes a critical distinction often overlooked by investors: WNA and Red Book reports show "operable" reactor capacity rather than actual operating production. As he explains, "These documents are not written for you and me. They are amazing in terms of the depth of the data they've got on a reactor-by-reactor basis and on a mine-by-mine basis." Historical production typically achieves only 70-84% of nameplate capacity, with an additional 12-24 month fuel cycle lag creating further misalignment between reported figures and market reality.

When asked whether uranium represents a momentum play or structural deficit investment, Frostad was unequivocal: "Oh, it's a structural deficit play." The market is currently experiencing a genuine deficit masked by inventory buffers and secondary supplies that are nearing depletion. Japan's first uranium order in 11 years signals that these buffers are reaching their limits.

The contracting situation underscores market tightness, with 70% of post-2027 demand remaining uncontracted—the highest level in 30 years. Supply-side challenges persist as "there's certainly a lot more things going wrong on the supply side than going right," according to Frostad, with projects facing permitting delays, financing hurdles, and operational disruptions.

Unlike the speculative 2007 uranium bull market focused on "pounds in the ground," current demand is fundamentally different. As Frostad notes, "the price of uranium is not the issue whatsoever. It's the access." Policy-backed energy security concerns and decarbonization commitments drive this cycle, with political support strengthening globally across previously anti-nuclear jurisdictions.

For investors, the key insight is recognizing that multiple indicators—depleting inventories, reduced enrichment underfeeding capacity, and persistent supply disruptions—point to an approaching inflection point that will likely trigger rapid price discovery in this small, inelastic market.

Sign up for Crux Investor: https://cruxinvestor.com